John G. Roubil, MD

Chief Resident (PGY-5) @VCURadOncRes via @umasschan | mostly NBA Twitter/New England Sports | Demoulas Market Basket stan

[John G. Roubil, MD @JohnRoubil]

The most RadOnc thing I’ve ever read 😂 ☢️ #radonc #MedTwitter #oncology

[ArtButMakeItSports @ArtButSports]

Upwards, by Wassily Kandinsky, 1929, (rotated, detail), 📸 by Lars Baron

[Navid Fallahi MD, MPH @NavidFallahi_MD]

Now offering group licensing for Rad Onc Oral Board Sim (version 1.3.3). If you are a residency program interested in group subscriptions for your residents, please contact me at [email protected] #RadOnc #ABR #MedEd
https://t.co/LBC0efSoz5

[Navid Fallahi MD, MPH @NavidFallahi_MD]

Studying for Rad Onc Oral Boards? Try out my app Rad Onc Oral Board Sim! It uses AI to generate unique cases and evaluates your spoken responses like a real board examiner. Let me know what you think! #RadOnc #ABR #MedEd
https://t.co/LBC0efSoz5

[Dr. Nina Niu Sanford @NiuSanford]

Happy to share this interactive contouring tutorial for dose-escalated RT in locally advanced pancreas ca, which follows our NRG consensus contouring atlas.

Thank you @johnroubil, @dsouzl, @aiims2738, & the @eContourRadOnc team for working on this case!

https://t.co/oxR785IKAD

[Mark Cuban @mcuban]

Well done ! Where you at @doj

Fixing healthcare starts with you making the biggest insurers divest non insurance related businesses.

And

Taking a hard look at the largest healthcare systems with market dominance

[Nicholas Zaorsky, MD MS @NicholasZaorsky]

Thank you for having me @VCURadOncRes @VCUMassey @emmacfields @JohnRoubil @NavidFallahi_MD @ElianeGarlock @natem214 @aleckonradmed @SII2023 @JoeWildingMD
@AmandaStarkMD

[VCU Radiation Oncology Residency @VCURadOncRes]

Fellow chief resident John Roubil (@JohnRoubil) had an oral presentation on his working with @StJude attending Dr. Lucas looking at patterns of failure after pencil beam scanning proton therapy in pediatric patients #ASTRO25

[John G. Roubil, MD @JohnRoubil]

@_EmilyHollis The coffee shop in the Sales Force tower - you walk through an urban park with exotic plants inside the building to get there!

https://t.co/aS0mN3opSO

[John G. Roubil, MD @JohnRoubil]

@eContourRadOnc @FoxChaseCancer @gauravmarwaha @RushRadOnc 👏🏼👏🏼👏🏼 @UMassChan #whyumassmed

[John G. Roubil, MD @JohnRoubil]

@ElianeGarlock 🎉🙌🏽

[VCU Radiation Oncology Residency @VCURadOncRes]

We are so excited to have our new PGY2s join us this week!
Thanks for joining the crew, Lauren, Amanda, and @aleckonradmed. Happy to have you on board!

[John G. Roubil, MD @JohnRoubil]

@Advances_ASTRO Congratulations @RachelJimenezMD ! 🎉

[John G. Roubil, MD @JohnRoubil]

@SchultzKurt @colontown @PSOGI_EC @SocSurgOnc @GusGodley @DavidSuMD @gunderson_craig @kanwal_raghav @umutsarpel @jpshen_md @manjuggm @kturaga Congratulations Kurt!

[Reads with Ravi @readswithravi]

How much you learn:

[John G. Roubil, MD @JohnRoubil]

@jfcdrr @ASTRO_org @QuadShotNews @LauraDoverMD @Raj_Singh_MD @EricLehrer @joshuapalmermd @VCURadOncRes @VCUMassey @marslain Both LINAC and Gamma Knife

[John G. Roubil, MD @JohnRoubil]

Thank you for highlighting our work in ProShot (@ASTRO_org) #PracticalRO & @QuadShotNews ! @LauraDoverMD @Raj_Singh_MD @EricLehrer @joshuapalmermd
@VCURadOncRes @VCUMassey

https://t.co/kOrBK9yNVC

[John G. Roubil, MD @JohnRoubil]

Do SRS margins really impact local control and/or radionecrosis when treating brain mets?

@Raj_Singh_MD @EricLehrer @joshuapalmermd

👇🏼👇🏼👇🏼
https://t.co/kOrBK9yNVC

[ACS Journal Cancer @JournalCancer]

New from @Raj_Singh_MD et al | Clinical outcomes following stereotactic radiosurgery for brain metastases from sarcoma primaries: An international multicenter analysis

https://t.co/eWGK0bFwuk

@OncoAlert #sarcoma #radonc

[John G. Roubil, MD @JohnRoubil]

@AmericanCancer @IntRRF @Raj_Singh_MD @jasonpsheehan @joshuapalmermd @VCURadOncRes @VCUMassey

[John G. Roubil, MD @JohnRoubil]

Full manuscript is now available in @JournalCancer - this is the largest series of SRS for sarcoma brain mets now showing excellent contemporary OS outcomes (~3 mons ⏭️ 11.2 mons), with histology/ECM and age as drivers of OS and LC respectively.

[Raj Singh, MD @Raj_Singh_MD]

Excellent presentation ⁦@ACRORadOnc⁩ #ACRO2025 by ⁦⁦@JohnRoubil⁩ on ⁦@IntRRF⁩ analysis on SRS for sarcoma brain metastases, showing favorable LC & OS. Leiomyosarcoma histologies and pts w/o progressive extracranial metastases had better OS ⁦⁩

[John G. Roubil, MD @JohnRoubil]

@AmericanCancer @IntRRF @Raj_Singh_MD @jasonpsheehan @joshuapalmermd